Rasch analysis suggests that health assessment questionnaire II is a generic measure of physical functioning for rheumatic diseases: a cross-sectional study.

about

Rasch analysis suggests that health assessment questionnaire II is a generic measure of physical functioning for rheumatic diseases: a cross-sectional study.

Item

http://www.wikidata.org/entity/Q55241374

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Rasch analysis suggests that h ...... ases: a cross-sectional study.

@en

Rasch analysis suggests that h ...... ases: a cross-sectional study.

@nl

type

Item

label

Rasch analysis suggests that h ...... ases: a cross-sectional study.

@en

Rasch analysis suggests that h ...... ases: a cross-sectional study.

@nl

prefLabel

Rasch analysis suggests that h ...... ases: a cross-sectional study.

@en

Rasch analysis suggests that h ...... ases: a cross-sectional study.

@nl

P1476

Rasch analysis suggests that h ...... eases: a cross-sectional study

@en

P2093

Ketna Parekh

http://www.w3.org/2001/XMLSchema#string

P2860

Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials

RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.

Is the pain visual analogue scale linear and responsive to change? An exploration using Rasch analysis.

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?

Are we ready for computerized adaptive testing?

Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee.

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

Outcome domains for studies of acute and chronic gout.

P2888

s12955-018-0939-2

P304

108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12955-018-0939-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William J Taylor

P577

2018-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29848340

http://www.w3.org/2001/XMLSchema#string

P921

questionnaire

P932

5977461

http://www.w3.org/2001/XMLSchema#string